ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Startups

Born in a lab, startup Nalagenetics joins fight against ancient disease

Singapore gene testing company sees opportunities in Asia's health tech industry

Nalagenetics won its first major contract from the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua.

JAKARTA -- Leprosy was mostly wiped out in Indonesia two decades ago, but because it remains prevalent in some far-flung regions, the archipelago nation ranks third in cases of the disease after India and Brazil.

In remote villages in Papua and West Papua provinces, the Indonesian government's efforts to combat the disease have been hampered by life-threatening adverse reactions to a World Health Organization-recommended anti-leprosy medication called Dapsone. The reactions pose such a risk that some doctors have stopped administering the drug altogether.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more